Vivozon Holdings Reports No Change in Vivozon Pharmaceutical Stake but New Pledge of 4.5 Million Shares to SangSangin Savings Bank
Vivozon Holdings maintains its 19,787,259 shares or 31.72% stake in Vivozon Pharmaceutical unchanged, but has newly pledged 4.5 million shares or 7.21% to SangSangin Savings Bank for a 6.5 billion won loan at 11% interest with a 160% collateral maintenance ratio, indicating high leverage cost.
Following early redemption of exchangeable bonds, the remaining exchangeable shares decreased to 158,177 and related pledges were partially released, but existing pledges and exchangeable bond issuance to Synergy AI and Scale-up funds remain in place.
The filer states the purpose is to influence management, and together with special relations Vivozon and CEO Lee Doo-hyun, maintains stable control. Total assets of 54.3 billion won against debt of 21.6 billion won suggests moderate financial health.
[AI Summary]While the holding company's stake percentage is unchanged, the large new pledge for high-interest borrowing signals financial strain and potential margin risk if the stock price falls. Remaining exchangeable bonds pose a latent overhang, partially relieved by early redemption. Near-term stock upside appears limited.